S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Aging may affect a person's vision. Vitamin E and/or selenium may help prevent
cataracts or age-related macular degeneration in men receiving these drugs as part of a
clinical trial for the prevention of prostate cancer.
PURPOSE: This clinical trial is studying vitamin E and/or selenium to see how well they work
in preventing cataract and age-related macular degeneration in men enrolled on SELECT
(SWOG-S0000).
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
National Cancer Institute (NCI) National Eye Institute (NEI)
Treatments:
alpha-Tocopherol Selenium Tocopherols Tocotrienols Vitamin E Vitamins